Clovis Oncology
CLVS
$0.08120
Share price
0.00%
Change (1 day)
-95.08%
Change (1 year)
Categories
Clovis Oncology (CLVS) Fails to deliver data
Key failure to deliver metrics for Clovis Oncology:
- Last SEC data release: 2022-12-14
- Last 15 days FTD volume: $0.12 M
- Last 3 months FTD volume: $7.84 M
- Last year FTD volume: $96.73 M
Failures to deliver for Clovis Oncology (CLVS) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Clovis Oncology (CLVS) - since 2013
Volume in USD (price x number of shares), data since 2013Clovis Oncology (CLVS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2022 | $0.10 B | 55.95% |
| 2021 | $64.22 M | -74.65% |
| 2020 | $0.25 B | -49.12% |
| 2019 | $0.49 B | 1053.83% |
| 2018 | $43.14 M | 68.49% |
| 2017 | $25.6 M | -50.75% |
| 2016 | $51.99 M | 5.81% |
| 2015 | $49.14 M | -8.09% |
| 2014 | $53.46 M | 1150.43% |
| 2013 | $4.27 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.60 B | 🇺🇸 USA |
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 AbbVie ABBV | $8.76 M | $0.15 B | 🇺🇸 USA |
 Eli Lilly LLY | $50.92 M | $0.12 B | 🇺🇸 USA |
 AstraZeneca AZN | $0.10 B | $0.17 B | 🇬🇧 UK |
 BioMarin Pharmaceutical BMRN | $2.19 M | $7.77 M | 🇺🇸 USA |